Search Website Search Directory

UVM Cancer Center Logo

COLLEGE OF
MEDICINE
  • Home
  • About Us
    • Overview
    • Member Directory
    • Administration
    • Research
    • Employment Opportunities
  • Clinical Care
  • Resources
    • Shared Resources
    • Vermont Integrative Genomics Resource
    • Cancer Translational Research Laboratory
  • Research
    • Cancer Center Membership
    • Extramural Funding
    • Intramural Funding
    • Transdisciplinary Teams (TDTs)
    • Research Programs
    • Protocol Review
      • Protocol Review
      • Submission Requirements
      • Procedures
      • Relationship to IRB
      • UVM Commons Tool
  • Clinical Trials
    • Clinical Trials Office
    • Find A Cancer Trial
    • Services
    • FAQs
    • Contact Us
  • Community Outreach
  • Events
  • Make a Gift
    • Give to the UVM Cancer Center
    • Ways to Give
CONTACT US

  • $100,000 gift from the UVM Medical Center Auxiliary, Inc. will support the Breast Cancer Integrative Oncology Program
    July 24, 2022
  • UVM, Dartmouth, VTAAC Launch Public Education Program Promoting Early Detection of Lung Cancer
    July 7, 2022
  • Study First to Show Benefit of 3D Mammography in Reducing Late-stage Breast Cancer
    July 6, 2022
    In a Journal of American Medical Association study, researchers - including UVM Professor and UVM Cancer Center member Brian Sprague, Ph.D. - found that 3D screening with digital breast tomosynthesis had certain benefits compared to breast cancer screening with conventional 2D digital mammography.
  • Brundage Invested as Green & Gold Professor in Division of Otolaryngology, Head and Neck Surgery
    June 29, 2022
    In a formal ceremony held at the University of Vermont’s Larner College of Medicine on June 28, 2022, Associate Professor of Surgery William Brundage, M.D., was invested as the inaugural Green and Gold Professor in the Division of Otolaryngology, Head and Neck Surgery.
  • New Osher Center for Integrative Health to Benefit UVM Cancer Center Patients
    June 23, 2022
  • Breast Cancer Phase III Clinical Trial Now Open at UVM Cancer Center
    June 17, 2022
  • Clinical study looks at blood test to predict clotting risk in cancer patients
    May 24, 2022
  • Janssen-Heininger Honored as University Distinguished Professor
    May 17, 2022
    Yvonne Janssen-Heininger, Ph.D., professor of pathology and laboratory medicine at the UVM Larner College of Medicine, is a 2022 recipient of the University Distinguished Professor Award. This title is a career appointment, and is the highest academic honor that UVM can bestow upon a member of the faculty.
  • “Invisible Patients” – Research Reveals Tips for Caregivers
    May 2, 2022
  • UVM Cancer Center announces Summer Student Fellowships in Cancer Research Awardees
    April 14, 2022
  • Study Finds Exposure to Phthalates May Increase Children's Cancer Risk
    March 14, 2022
    In a first-of-its-kind study, research from the University of Vermont Cancer Center has linked phthalates, commonly called the “everywhere chemical,” to higher incidence of specific childhood cancers.
  • UVM Cancer Center researchers receive Northern New England Clinical Oncology Society (NNECOS) Collaborative Research Grant to study “Immunobrain”
    March 4, 2022
  • New Study Highlights Colorectal Cancer Treatments that Improve Patients' Quality of Life
    February 28, 2022
    In recent years, total neoadjuvant treatment—a potent new therapy for advanced colorectal cancer—has emerged as the standard of care. But the treatment can be harsh, impacting quality of life for many patients. A new study published in Clinical Colorectal Cancer by a team of researchers affiliated with the University of Vermont Cancer Center highlights a variety of new colorectal cancer treatments that take into account both a patient’s likely health outcome and quality of life factors.
  • UVM Cancer Researcher Frances Carr Elected AAAS Fellow
    February 16, 2022
    Frances Carr, Ph.D., professor of pharmacology at the Larner College of Medicine at the University of Vermont and UVM Cancer Center member, has been elected to the American Association for the Advancement of Science Fellows Class of 2021.
  • UVM Cancer Center Investigators Publish the Breast Pre-Cancer Atlas
    January 18, 2022
    UVM Cancer Center researchers contributed to the establishment of a breast pre-cancer atlas, which establishes the molecular and cellular properties of early-stage breast cancer and is the result of a six-year, National Cancer Institute-funded, collaborative initiative.
  • Maija Reblin, Ph.D. appointed co-leader for the UVM Cancer Center’s Cancer Control and Population Health Sciences program
    January 26, 2022
  • Summer Student Research Program Trains Next Generation of Cancer Scientists
    January 26, 2022
    The UVM Cancer Center Summer Student Fellowships in Cancer Research provide $3,000 stipends to graduate and medical students for cancer-related research projects, overseen by senior faculty members affiliated with the center.
  • Now Enrolling: Clinical Trial Tests Effectiveness of Online Strength Training in Slowing Muscle Wasting in Lung Cancer Patients
    January 18, 2022
  • Adrianzen Herrera Invested as Early Career Green & Gold Professor of Medicine
    January 13, 2022
    In a ceremony held January 12, 2021, an outstanding early career physician-scientist in the University of Vermont’s Larner College of Medicine, Diego Adrianzen Herrera, M.D., was invested as the inaugural holder of the Early Career Green and Gold Professor of Medicine.
  • UVM Cancer Center Announces 2021 Pilot Project Grantees
    January 12, 2022
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
News Sources
  • University of Vermont Medical Center
  • Larner College of Medicine News
Tweets by UVM Cancer Center
Accessibility | Privacy/Terms of Use
Copyright 2022 | Burlington, VT